Stephanie Kauffman, CEO of the Melanoma Research Alliance, discussed the organization's research priorities as it approaches 20 years of advancing melanoma research.
Stephanie Kauffman
Advertisement
Stephanie Kauffman is Chief Executive Officer of the Melanoma Research Alliance (MRA), the world's largest private nonprofit funder of melanoma research. She leads MRA's efforts to accelerate scientific discovery and translate research into meaningful advances for patients, bringing together philanthropy, academia, industry, government, and the patient community to advance prevention, early detection, treatment, and survivorship.
Articles by Stephanie Kauffman
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Dermatology Times
1
Personalized mRNA-Based Melanoma Vaccine Meets Primary Endpoints in Landmark Phase 3 Trial
2
LEO Pharma Acquires Potential First Oral Therapy for EPP and XLP
3
Q&A: What Tudriqev's Approval Means for PD-1-Refractory Melanoma
4
Skin & Psych: Using Habit Loop Science to Interrupt the Itch-Scratch Cycle
5